Insight investigation of rilpivirine and compounds from mushrooms as feline immunodeficiency virus reverse transcriptase inhibitors using molecular dynamics simulations and quantum chemical calculations

References

• Pedersen NC, Ho EW, Brown ML, et al. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science. 1987;235:790–793.
   PubMed Web of Science ®Google Scholar
• Sykes JE. Chapter 21 – feline immunodeficiency virus infection. In: Sykes JE, editor. Canine and feline infectious diseases. Saint Louis (MO): W.B. Saunders; 2014. p. 209–223.
   Google Scholar
• Sparger EE. FIV as a model for HIV: an overview. In: Friedman H, Specter S, and Bendinelli M, editors. In vivo models of HIV disease and control. Boston (MA): Springer; 2006. p. 149–237.
   Google Scholar
• Bendinelli M, Pistello M, Lombardi S, et al. Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen. Clin Microbiol Rev. 1995;8:87–112.
   PubMed Web of Science ®Google Scholar
• Eckstrand C, Sparger E, Murphy B. Central and peripheral reservoirs of feline immunodeficiency virus in cats: a review. J Gen Virol. 2017;98:1985–1996.
   PubMed Web of Science ®Google Scholar
• Westman M, Yang D, Green J, et al. Antibody responses in cats following primary and annual vaccination against feline immunodeficiency virus (FIV) with an inactivated whole-virus vaccine (Fel-O-Vax® FIV). Viruses. 2021;13:470.
   PubMed Web of Science ®Google Scholar
• Little S, Levy J, Hartmann K, et al. 2020 AAFP feline retrovirus testing and management guidelines. J Feline Med Surg. 2020;22:5–30.
   PubMed Web of Science ®Google Scholar
• Galilee M, Alian A. The structure of FIV reverse transcriptase and its implications for non-nucleoside inhibitor resistance. PLOS Pathogens. 2018;14:e1006849.
   PubMed Web of Science ®Google Scholar
• Öztürk M, Tel-Çayan G, Muhammad A, et al. Chapter 10 – mushrooms: a source of exciting bioactive compounds. In: Attaur R, editor. Studies in natural products chemistry. Amsterdam: Elsevier; 2015. p. 363–456.
   Google Scholar
• Cateni F, Gargano ML, Procida G, et al. Mycochemicals in wild and cultivated mushrooms: nutrition and health. Phytochem Rev. 2021.
   Web of Science ®Google Scholar
• Butkhup L, Samappito W, Jorjong S. Evaluation of bioactivities and phenolic contents of wild edible mushrooms from northeastern Thailand. Food Sci Biotechnol. 2018;27:193–202.
   PubMed Web of Science ®Google Scholar
• Zeb M, Lee CH. Medicinal properties and bioactive compounds from wild mushrooms native to North America. Molecules. 2021;26:251.
   PubMed Web of Science ®Google Scholar
• Reis FS, Martins A, Vasconcelos MH, et al. Functional foods based on extracts or compounds derived from mushrooms. Trends Food Sci Technol. 2017;66:48–62.
   Web of Science ®Google Scholar
• Mattila P, Könkö K, Eurola M, et al. Contents of vitamins, mineral elements, and some phenolic compounds in cultivated mushrooms. J Agric Food Chem. 2001;49:2343–2348.
   PubMed Web of Science ®Google Scholar
• Cheung PCK. Mini-review on edible mushrooms as source of dietary fiber: preparation and health benefits. Food Sci Hum Wellness. 2013;2:162–166.
   Google Scholar
• Paterson RRM. Ganoderma – a therapeutic fungal biofactory. Phytochemistry. 2006;67:1985–2001.
   PubMed Web of Science ®Google Scholar
• Cör D, Knez Ž, Hrnčič MK. Antitumour, antimicrobial, antioxidant and antiacetylcholinesterase effect of Ganoderma lucidum terpenoids and polysaccharides: a review. Molecules. 2018;23:649.
   PubMed Web of Science ®Google Scholar
• Mohamed E, Farghaly F. Bioactive compounds of fresh and dried Pleurotus ostreatus mushroom. Int J Biotechnol Wellness Ind. 2014;3:4–14.
   Google Scholar
• Chen PX, Wang S, Nie S, et al. Properties of Cordyceps sinensis: a review. J Funct Foods. 2013;5:550–569.
   PubMed Web of Science ®Google Scholar
• Shashidhar MG, Giridhar P, Sankar KU, et al. Bioactive principles from Cordyceps sinensis: a potent food supplement – a review. J Funct Foods. 2013;5:1013–1030.
   PubMed Web of Science ®Google Scholar
• Guggenheim AG, Wright KM, Zwickey HL. Immune modulation from five major mushrooms: application to integrative oncology. Integr Med. 2014;13:32–44.
   Google Scholar
• Fernandes PDT, Chaquisse E, Ferrão J. HIV and the antiviral role of mushroom nutraceuticals. EJAS. 2020;8:64–100.
   Google Scholar
• Tochikura TS, Nakashima H, Ohashi Y, et al. Inhibition (in vitro) of replication and of the cytopathic effect of human immunodeficiency virus by an extract of the culture medium of Lentinus edodes mycelia. Med Microbiol Immunol. 1988;177:235–244.
   PubMed Web of Science ®Google Scholar
• Seetaha S, Ratanabunyong S, Tabtimmai L, et al. Anti-feline immunodeficiency virus reverse transcriptase properties of some medicinal and edible mushrooms. Vet world. 2020;13:1798–1806.
   PubMed Web of Science ®Google Scholar
• Bhardwaj VK, Purohit R, Kumar S. Himalayan bioactive molecules as potential entry inhibitors for the human immunodeficiency virus. Food Chem. 2021;347:128932.
   PubMed Web of Science ®Google Scholar
• Singh R, Bhardwaj V, Das P, et al. Natural analogues inhibiting selective cyclin-dependent kinase protein isoforms: a computational perspective. J Biomol Struct Dyn. 2021;38:5126–5135.
   Web of Science ®Google Scholar
• Bhardwaj VK, Purohit R. Targeting the protein-protein interface pocket of Aurora-A-TPX2 complex: rational drug design and validation. J Biomol Struct Dyn. 2021;39:3882–3891.
   PubMed Web of Science ®Google Scholar
• Kuno M, Hannongbua S, Morokuma K. Theoretical investigation on nevirapine and HIV-1 reverse transcriptase binding site interaction, based on ONIOM method. Chem Phys Lett. 2003;380:456–463.
   Web of Science ®Google Scholar
• Honorio P, Sainimnuan S, Hannongbua S, et al. Binding interaction of protoberberine alkaloids against acetylcholinesterase (AChE) using molecular dynamics simulations and QM/MM calculations. Chem Biol Interact. 2021;344:109523.
   PubMed Web of Science ®Google Scholar
• Waterhouse A, Bertoni M, Bienert S, et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 2018;46:W296–W303.
   PubMed Web of Science ®Google Scholar
• Colovos C, Yeates TO. Verification of protein structures: patterns of nonbonded atomic interactions. Protein Science. 1993;2:1511–1519.
   PubMed Web of Science ®Google Scholar
• Lüthy R, Bowie JU, Eisenberg D. Assessment of protein models with three-dimensional profiles. Nature. 1992;356:83–85.
   PubMed Web of Science ®Google Scholar
• Carugo O, Djinovic-Carugo K. Half a century of Ramachandran plots. Acta Crystallogr D Biol Crystallogr. 2013;69:1333–1341.
   PubMedGoogle Scholar
• Van Der Spoel D, Lindahl E, Hess B, et al. GROMACS: fast, flexible, and free. J Comput Chem. 2005;26:1701–1718.
   PubMed Web of Science ®Google Scholar
• Dassault Systems. BIOVIA discovery studio. Dassault Systems BIOVIA, Discovery Studio Modeling Environment, Release 2017. 2016, Dassault Systems.
   Google Scholar
• Frisch MJ, Trucks GW, Schlegel HB, et al. Gaussian 09, revision D.01. Wallingford (CT): Gaussian, Inc.; 2009.
   Google Scholar
• Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7:42717.
   PubMed Web of Science ®Google Scholar
• Jones G, Willett P, Glen RC, et al. Development and validation of a genetic algorithm for flexible docking. J Mol Biol. 1997;267:727–748.
   PubMed Web of Science ®Google Scholar
• Kumari R, Kumar R, Lynn A. g_mmpbsa—A GROMACS tool for high-throughput MM-PBSA calculations. J Chem Inf Model. 2014;54:1951–1962.
   PubMed Web of Science ®Google Scholar
• Dapprich S, Komaromi I, Byun KS, et al. A new ONIOM implementation in Gaussian98. Part I. The calculation of energies, gradients, vibrational frequencies and electric field derivatives. J Mol Struc: Theochem. 1999;461–462:1–21.
   Web of Science ®Google Scholar
• Messaoudi A, Belguith H, Ben Hamida J. Homology modeling and virtual screening approaches to identify potent inhibitors of VEB-1 β-lactamase. Theor Biol Med Model. 2013;10:22.
   PubMed Web of Science ®Google Scholar
• Jia JM, Tao HH, Feng BM. Cordyceamides A and B from the culture liquid of Cordyceps sinensis (Berk.) Sacc. Chem Pharm Bull. 2009;57:99–101.
   PubMed Web of Science ®Google Scholar
• Chen B, Sun Y, Luo F, et al. Bioactive metabolites and potential mycotoxins produced by Cordyceps fungi: a review of safety. Toxins. 2020;12:410.
   Web of Science ®Google Scholar
• Chen L, Liu Y, Jia D, et al. Pharmacokinetics and biodistribution of aurantiamide and aurantiamide acetate in rats after oral administration of Portulaca oleracea L. extracts. J Agric Food Chem. 2016;64:3445–3455.
   PubMed Web of Science ®Google Scholar
• Sander T, Freyss J, Kor M, et al. DataWarrior: an open-source program for chemistry aware data visualization and analysis. J Chem Inf Model. 2015;55:460–473.
   PubMed Web of Science ®Google Scholar
• Paton RS, Goodman JM. Hydrogen bonding and pi-stacking: how reliable are force fields? A critical evaluation of force field descriptions of nonbonded interactions. J Chem Inf Model. 2009;49:944–955.
   PubMed Web of Science ®Google Scholar
• Wang E, Sun H, Wang J, et al. End-point binding free energy calculation with MM/PBSA and MM/GBSA: strategies and applications in drug design. Chem Rev. 2019;119:9478–9508.
   PubMed Web of Science ®Google Scholar